1. Latest Lipid Guidelines in Perspective

3. What's New in the 2018 Cholesterol Guideline?

4. 10-Year Risk Score

5. 10-Year Risk for ASCVD[a]

6. Beyond Statins -- Getting LDL to Goal

7. Identify Patients With Statin Intolerance

8. Alirocumab and Evolocumab

9. Guideline Term Update

10. GAUSS-3 Study Design 2 Double-Blind Phases

11. GAUSS-3 Takeaway Points

12. Nonstatin Treatments

13. Risk-Enhancing Factors for Primary Prevention*

14. 10-Year Risk Calculation Is Just the Beginning

15. Risk of Elevated Lp(a) in General Population

16. Statins Increase Coronary Calcium

17. CAC Measurement Recommendations

18. CAC -- Use With Caution

19. Fasting Lipid Profiles

20. Who Gets Treated With a PCSK9 Inhibitor

21. Normal and Abnormal Lipid Values in Childhood

22. Key Take-Home Messages

23. Shared Clinician-Patient Decision Making

24. Abbreviations

25. Abbreviations (cont)